News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pacira Pharmaceuticals, Inc. Raises $42M, Opens Flat Post-IPO After Slashing Price


2/3/2011 6:49:39 AM

Wall Street Journal -- Pacira Pharmaceuticals Inc. generated little interest among investors on its first day of trading Thursday, even after it cut its offering price in half.The company's stock opened at $7 a share on the Nasdaq, flat with its initial public offering price. It sold six million shares, nearly two million more than expected, but at a greatly reduced price. The company had originally set out to sell its stock within a $14 to $16 range.

Read at BioSpace.com
Read at Bloomberg
Read at Xconomy
Read at Wall Street Journal

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES